
Long-Acting Amylin Receptor Agonist
Cagrilintide is a long-acting analog of amylin designed for metabolic disease research. Biolyn supplies pharmaceutical-grade Cagrilintide for B2B research and formulation applications.
A synthetic acylated amylin analog with modifications for extended half-life. Acts on amylin receptors (AMY1-3) to regulate energy balance and glucose homeostasis.